03.14.19
JSR has established a U.S. headquarters for its biotechnology and life sciences focused businesses under the name JSR Life Sciences, LLC effective April 1, 2019.
JSR Life Sciences will be a subsidiary of also newly established U.S.-based JSR North America Holdings, Inc. and will operate as a strategic leader of JSR’s biotech and life sciences focused businesses and affiliate companies including MBL, KBI Biopharma, Selexis, Crown Bioscience and other affiliates throughout Europe and the Asia-Pacific region.
Until now “JSR Life Sciences” served primarily as a brand name under which JSR developed and sold advanced materials and products for the biotech industry. This reorganization will foster new synergies among the companies’ different focus areas.
“This is an important step in further uniting the amazing talent and technologies of the JSR Life Sciences companies,” said Eric Johnson, president, JSR Life Sciences, LLC and JSR North America Holdings, Inc. “We are creating a center of gravity for our biotech-focused businesses. A U.S. headquarters supports our commitment to innovating throughout the life sciences industry because it puts us into closer contact with industry leading companies throughout both the U.S. and EU, while always remembering that it is our heritage as a Japanese company that has given us a solid, enduring foundation on which to build.”
JSR Life Sciences will be a subsidiary of also newly established U.S.-based JSR North America Holdings, Inc. and will operate as a strategic leader of JSR’s biotech and life sciences focused businesses and affiliate companies including MBL, KBI Biopharma, Selexis, Crown Bioscience and other affiliates throughout Europe and the Asia-Pacific region.
Until now “JSR Life Sciences” served primarily as a brand name under which JSR developed and sold advanced materials and products for the biotech industry. This reorganization will foster new synergies among the companies’ different focus areas.
“This is an important step in further uniting the amazing talent and technologies of the JSR Life Sciences companies,” said Eric Johnson, president, JSR Life Sciences, LLC and JSR North America Holdings, Inc. “We are creating a center of gravity for our biotech-focused businesses. A U.S. headquarters supports our commitment to innovating throughout the life sciences industry because it puts us into closer contact with industry leading companies throughout both the U.S. and EU, while always remembering that it is our heritage as a Japanese company that has given us a solid, enduring foundation on which to build.”
